2485-71-4 Usage
Description
13-METHYLTETRADECANOIC ACID, also known as Iso 15:0 Fatty Acid, is a branched-chain saturated fatty acid that is part of the family of branched chain fatty acids (BCFA). It is characterized by the presence of a methyl group substitution at position 13 on the tetradecanoic (myristic) acid. This unique structure is derived from soy fermentation products and has been identified in various natural sources such as dairy ewe rumen liquor, bovine milk, goat milk fat, the edible flesh of rainbow trout (O. mykiss), and Flavobacterium.
Uses
Used in Pharmaceutical Industry:
13-METHYLTETRADECANOIC ACID is used as a pharmaceutical compound for its potential therapeutic applications. The branched-chain structure of this fatty acid may contribute to its unique properties, making it a valuable candidate for the development of new drugs and therapies.
Used in Nutritional Supplements:
In the nutritional supplement industry, 13-METHYLTETRADECANOIC ACID is used as an ingredient in various health and wellness products. Its presence in natural sources like milk and fish suggests potential benefits for human health, and it may be incorporated into supplements to support overall well-being.
Used in Food Industry:
13-METHYLTETRADECANOIC ACID is used as an additive in the food industry, where it may be utilized to enhance the flavor, texture, or nutritional profile of certain products. Its natural occurrence in various food sources indicates its potential for safe use in the culinary world.
Used in Cosmetics Industry:
In the cosmetics industry, 13-METHYLTETRADECANOIC ACID is used as an ingredient in skincare and personal care products. Its unique properties may contribute to the development of innovative formulations that address specific skin concerns or provide targeted benefits.
Used in Research and Development:
13-METHYLTETRADECANOIC ACID is used as a research compound for the study of its chemical properties, biological activities, and potential applications in various fields. This may include investigations into its role in cellular processes, interactions with other molecules, and its potential for use in the development of new technologies or products.
Biochem/physiol Actions
Iso 15:0 fatty acid possesses anti-cancer activity in various human cancer cells.
Check Digit Verification of cas no
The CAS Registry Mumber 2485-71-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,4,8 and 5 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 2485-71:
(6*2)+(5*4)+(4*8)+(3*5)+(2*7)+(1*1)=94
94 % 10 = 4
So 2485-71-4 is a valid CAS Registry Number.
InChI:InChI=1/C15H30O2/c1-14(2)12-10-8-6-4-3-5-7-9-11-13-15(16)17/h14H,3-13H2,1-2H3,(H,16,17)
2485-71-4Relevant articles and documents
Lipid length and iso-branching of trehalose diesters influences Mincle agonist activity
Khan, Ayesha,Kodar, Kristel,Timmer, Mattie S.M.,Stocker, Bridget L.
, p. 1269 - 1277 (2018)
We report on the efficient synthesis of linear trehalose diesters (TDEs) and iso-branched TDEs (maradolipids or iso-TDEs) and their ability to activate bone marrow-derived macrophages (BMDMs) as determined by cytokine (IL-1β IL-12, IL-6, IL-10) and chemokine (MIP-2) production. Both classes of TDEs were found to activate BMDMs in a Mincle-dependent manner, with longer-chain (≥C18) lipids leading to a robust inflammatory response. On the whole, the iso-branched TDEs led to greater cytokine production and a faster immune response when compared to their linear counterparts. Moreover, C12-TDE and iso-C12-TDE elicited the production of MIP-2 by BMDMs, thereby providing the first example of TDEs with a chain length of ≤ C12 leading to a Mincle-dependent immune response and one that is less inflammatory in nature.
Synthesis of sphingosine relatives. Part 22. Synthesis of sulfobacin A, B and flavocristamide A, new sulfonolipids isolated from Chryseobacterium sp.
Takikawa, Hirosato,Nozawa, Dai,Kayo, Akihiro,Muto, Shin-Etsu,Mori, Kenji
, p. 2467 - 2477 (1999)
Sulfobacin A (1), B (2), and flavocristamide A (3), new sulfonolipids isolated from Chryseobacterium sp. were synthesized stereoselectively by starting from L-cysteine.
SYNTHETIC INNATE IMMUNE RECEPTOR LIGANDS AND USES THEREOF
-
Paragraph 0050; 0074, (2020/06/10)
An adjuvant formulation includes a monophosphoryl Lipid A (MPLA) analogue, a Pam3CSK4 analogue, or a muramyldipeptide (MDP) analogue, or combinations thereof. The adjuvant may be formulated in soluble form or in a nanoparticle, such as polylactic glycolic acid nanoparticles. A vaccine formulation comprises the adjuvant formulation and an immunogen. Methods of vaccinating an animal include delivering the vaccine formulation to the animal.
COMPOSITIONS SOUS FORME D'UNE SOLUTION AQUEUSE INJECTABLE COMPRENANT DU GLUCAGON HUMAIN ET UN CO-POLYAMINOACIDE
-
Paragraph 1070-1074, (2019/09/20)
Physically stable compositions in the form of an injectable aqueous solution, wherein the pH is from 6.0 to 8.0, includes at least: a) human glucagon andb) a co-polyamino acid bearing carboxylate charges and hydrophobic radicals Hy. In one embodiment, the compositions further comprise a gut hormone.
